(2E,2′E)-3,3′-(1,4-phenylene)bis(1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one) | 1584741-37-6

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: (2E,2′E)-3,3′-(1,4-phenylene)bis(1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one)
• 英文别名: 1′,4′-bis-(E/E)-[1-(3′′,4′′,5′′-trimethoxylphenyl)-prop-1-oxo-2-enyl]benzene；(E)-3-[4-[(E)-3-oxo-3-(3,4,5-trimethoxyphenyl)prop-1-enyl]phenyl]-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
• CAS: 1584741-37-6
• 化学式: C₃₀H₃₀O₈
• 分子量: 518.563
• InChiKey: CGPZKBGXLSYETP-PHEQNACWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  38
• 可旋转键数：
  12
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  89.5
• 氢给体数：
  0
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  3',4',5'-三甲氧基苯乙酮 、 对苯二甲醛 在 potassium hydroxide 作用下， 以 甲醇 为溶剂， 以96%的产率得到(2E,2′E)-3,3′-(1,4-phenylene)bis(1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one)
  参考文献：
  名称：

  新型姜黄素模拟物 Van D 的设计、合成和耐药逆转潜力

  摘要：

  作为以植物为基础的自然资源新药物发现的关键部分，一项研究旨在探索姜黄素模拟物与抗生素联合对抗铜绿假单胞菌多药耐药菌株的抗菌潜力。最好的候选药物Van D，姜黄素模拟物将四环素 (TET) 对多药耐药临床分离株的 MIC 降低了 16 倍。VanD 进一步抑制了外排泵，如溴化乙锭外排和计算机对接研究所证明的那样。在另一项实验中，还发现Van D抑制生物膜合成。这种衍生物可杀死 KG-P2，一种铜绿假单胞菌的分离物以时间依赖性方式，四环素的抗生素后效应（PAE）延长，TET的突变预防浓度（MPC）也降低。在瑞士白化小鼠中，Van D降低了促炎细胞因子的浓度。在急性口服毒性研究中，该衍生物具有良好的耐受性，并发现高达 1000 mg/kg 的剂量是安全的。据我们所知，这是关于姜黄素模拟物通过抑制外排泵作为增效剂的第一份报告。

  DOI：

  10.1016/j.bioorg.2020.104454

文献信息

• Design, synthesis and drug resistance reversal potential of novel curcumin mimics Van D
  作者：Gaurav Raj Dwivedi、Sadiya Khwaja、Arvind Singh Negi、Swati S. Panda、A. Swaroop Sanket、Sanghamitra Pati、Amit Chand Gupta、Dnyaneshwar Umrao Bawankule、Debabrata Chanda、Rajni Kant、Mahendra P. Darokar

  DOI：10.1016/j.bioorg.2020.104454

  日期：2021.1

  crucial part of plant-based novel discovery of drug from natural resources, a study was done to explore the antibacterial potential of curcumin mimics in combination with antibiotics against multidrug resistant isolates of Pseudomonas aeruginosa. The best candidate Van D, a curcumin mimics reduced the MIC of tetracycline (TET) up to 16 folds against multidrug resistant clinical isolates. VanD further inhibited

  作为以植物为基础的自然资源新药物发现的关键部分，一项研究旨在探索姜黄素模拟物与抗生素联合对抗铜绿假单胞菌多药耐药菌株的抗菌潜力。最好的候选药物Van D，姜黄素模拟物将四环素 (TET) 对多药耐药临床分离株的 MIC 降低了 16 倍。VanD 进一步抑制了外排泵，如溴化乙锭外排和计算机对接研究所证明的那样。在另一项实验中，还发现Van D抑制生物膜合成。这种衍生物可杀死 KG-P2，一种铜绿假单胞菌的分离物以时间依赖性方式，四环素的抗生素后效应（PAE）延长，TET的突变预防浓度（MPC）也降低。在瑞士白化小鼠中，Van D降低了促炎细胞因子的浓度。在急性口服毒性研究中，该衍生物具有良好的耐受性，并发现高达 1000 mg/kg 的剂量是安全的。据我们所知，这是关于姜黄素模拟物通过抑制外排泵作为增效剂的第一份报告。
• Antiproliferative efficacy of curcumin mimics through microtubule destabilization
  作者：Sadiya Khwaja、Kaneez Fatima、Mohammad Hasanain、Chittaranjan Behera、Avneet Kour、Arjun Singh、Suaib Luqman、Jayanta Sarkar、Debabrata Chanda、Karuna Shanker、A.K. Gupta、D.M. Mondhe、Arvind S. Negi

  DOI：10.1016/j.ejmech.2018.03.063

  日期：2018.5

  Curcumin possesses an attractive chemical structure with highly conjugated diferuloylmethane core. Curcumin mimics have been designed and prepared with an additional bridged phenyl ring in conjugation. Fourteen diverse analogues were evaluated against a panel of human cancer cell lines. The best analogue of the series i.e. compound 6a exhibited potent cytotoxicity against A431, epidermoid carcinoma cell line (IC50 = 1.5 mu M) and DLDI, colorectal adenocarcinoma cell line (IC50 = 6.9 mu M). In tubulin kinetics experiment, compound 6a destabilized polymerisation process (IC50 = 4.68 mu M). In cell cycle analysis, compound 6a exerted G2/M phase arrest in A431 cells and induced apoptosis. In Ehrlich Ascites Carcinoma in Swiss-albino mice, compound 6a showed 78.6% tumour reduction at 80 mg/kg dose and 57% solid tumour reduction at 150 mg/kg dose. Further, in acute-oral toxicity experiment in rodent model, compound 6a was given in three different oral doses to Swiss albino mice. There were nonsignificant changes in various biochemical parameters and major body organs studied, including their absolute and relative weights. It was tolerable up to 300 mg/kg dose in Swiss -albino mice. The present study shows that the novel curcumin mimic 6a is a safe and efficacious anticancer compound. However, it needs to be optimized for better efficacy. (C) 2018 Elsevier Masson SAS. All rights reserved.
• Symmetric Bis-chalcones as a New Type of Breast Cancer Resistance Protein Inhibitors with a Mechanism Different from That of Chromones
  作者：Evelyn Winter、Patrícia Devantier Neuenfeldt、Louise Domeneghini Chiaradia-Delatorre、Charlotte Gauthier、Rosendo Augusto Yunes、Ricardo José Nunes、Tânia Beatriz Creczynski-Pasa、Attilio Di Pietro

  DOI：10.1021/jm401879z

  日期：2014.4.10

  Potent ABCG2 inhibitors were recently identified as asymmetric chromones with different types of substituents. We here synthesized symmetric bis-chalcones that were differently substituted and screened for their ability to inhibit mitoxantrone efflux from ABCG2-transfected HEK293 cells. Potent bis-chalcone inhibitors were identified, the efficiency depending on both position of the central ketone groups and the number and positions of lateral methoxy substituents. The best derivative, namely, 1p, was selective for ABCG2 over P-glycoprotein and MRP1, appeared not to be transported by ABCG2, and was at least as active on various drug-selected cancer cells overexpressing ABCG2. Compound 1p stimulated the ABCG2 basal ATPase activity by contrast to a chromone lead that inhibited it, suggesting different mechanisms of interaction. Combination of both types of inhibitors produced synergistic effects, leading to complete inhibition at very low
• Rational design, synthesis, and pharmacological characterisation of dicarbonyl curcuminoid analogues with improved stability against lung cancer via ROS and ER stress mediated cell apoptosis and pyroptosis
  作者：Tao Wei、Zhiwei Zheng、Xiaoyan Wei、Yugang Liu、Wentao Li、Bingqing Fang、Di Yun、Zhaojun Dong、Baozhu Yi、Wulan Li、Xiaoping Wu、Dezhi Chen、Liping Chen、Jianzhang Wu

  DOI：10.1080/14756366.2022.2116015

  日期：2022.12.31

  clinical applications. In this article, two types of dicarbonyl curcumin analogues with improved stability were designed through the calculation of molecular stability by density functional theory. Twenty compounds were synthesised, and their anti-tumour activity was screened. A plurality of analogues had significantly stronger activity than curcumin. In particular, compound B2 ((2E,2′E)-3,3′-(1,4-

  摘要 姜黄素是一种具有广泛抗肿瘤活性的天然药物。然而，由于β-二酮部分，姜黄素表现出较差的稳定性和药代动力学，极大地限制了其临床应用。在本文中，通过密度泛函理论计算分子稳定性，设计了两种稳定性得到改善的二羰基姜黄素类似物。合成了二十种化合物，并筛选了它们的抗肿瘤活性。多种类似物的活性明显强于姜黄素。特别是化合物 B2 ((2E,2'E)-3,3'-(1,4-phenylene)bis(1-(2-chlorophenyl)prop-2-en-1-one)) 表现出优异的抗体内和体外肺癌活性. 此外，B2可以上调肺癌细胞中活性氧的水平，进而激活内质网应激，导致细胞凋亡和细胞焦亡。总之，姜黄素类似物 B2 有望成为肺癌治疗的新候选药物，具有改善的化学和生物学特性。